Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 30.55%23.34M | 36.04%96.14M | -14.56%16.55M | 8.39%14.44M | 2.41%23.73M | 21.36%17.88M | 25.77%70.67M | 20.79%19.38M | 45.39%13.32M | 24.35%23.17M |
| Cost of revenue | 40.47%10.94M | 36.09%39.57M | 4.43%7.85M | 23.54%6.24M | -6.16%9.71M | 27.48%7.79M | 22.98%29.07M | 20.79%7.51M | 24.80%5.05M | 29.68%10.35M |
| Gross profit | 22.90%12.4M | 36.00%56.57M | -26.60%8.71M | -0.86%8.2M | 9.32%14.02M | 17.02%10.09M | 27.80%41.6M | 20.78%11.86M | 61.69%8.27M | 20.35%12.83M |
| Operating expense | -12.48%10.96M | 55.14%75.23M | 11.72%16.95M | 19.97%13.27M | 14.09%14.29M | 21.61%12.53M | 26.89%48.49M | 13.24%15.17M | 28.40%11.06M | 39.64%12.53M |
| Selling and administrative expenses | 8.15%13.55M | 55.65%75.48M | 11.72%16.95M | 19.97%13.27M | 14.09%14.29M | 21.61%12.53M | 26.90%48.5M | 13.24%15.17M | 28.40%11.06M | 39.64%12.53M |
| -Selling and marketing expense | 9.86%11.42M | 49.46%58.77M | 4.18%13.02M | 21.69%11M | 21.78%12.08M | 22.44%10.4M | 35.71%39.32M | 31.32%12.5M | 32.09%9.04M | 39.28%9.92M |
| -General and administrative expense | -0.19%2.13M | 82.13%16.71M | 47.01%3.93M | 12.26%2.26M | -15.20%2.21M | 17.73%2.13M | -0.71%9.18M | -31.13%2.67M | 14.10%2.02M | 41.02%2.61M |
| Other operating expenses | ---- | -6,024.01%-253.53K | ---- | ---- | ---- | ---- | ---4.14K | ---- | ---- | ---- |
| Total other operating income | --2.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 158.79%1.43M | -170.55%-18.66M | -149.26%-8.24M | -81.71%-5.07M | -191.28%-272K | -45.18%-2.44M | -21.67%-6.9M | 7.51%-3.31M | 20.27%-2.79M | -82.31%298K |
| Net non-operating interest income (expenses) | -938.71%-1.29M | -34.80%-2.79M | -5,597.92%-5.28M | 53.37%-159K | 73.17%-99K | 67.28%-124K | -71.27%-2.07M | 150.03%96K | -6.23%-341K | -6.03%-369K |
| Non-operating interest income | ---- | 77.03%3.19M | ---- | ---- | ---- | ---- | 400.08%1.8M | --96K | ---- | ---- |
| Non-operating interest expense | 938.71%1.29M | 54.44%5.98M | 5,667.28%5.28M | -53.37%159K | -73.17%99K | -67.28%124K | 146.71%3.87M | -117.18%-94.8K | 6.23%341K | 6.03%369K |
| Net investment income | -47.33%352.96K | 130.04%670.17K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -68.54%2.45M | -298.50%-2.13M | 0 | -82K | 80K | 459.28%7.8M | -535K | 0 | 0 | |
| Less:Restructuring and mergern&acquisition | ---- | --0 | ---- | ---- | ---- | ---- | ---5.3M | ---- | ---- | ---- |
| Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | ---32.04K | ---- | ---- | ---- |
| Less:Other special charges | ---- | 0.43%-2.45M | ---- | ---- | ---- | ---- | -128.50%-2.46M | ---- | ---- | ---- |
| Less:Write off | ---- | --0 | 298.50%2.13M | --0 | --82K | ---80K | --0 | --535K | --0 | --0 |
| Other non-operating income (expenses) | 66.68%8.84M | 48.65%8.21M | 26.40%2.07M | -70.35%1.96M | 85.69%1.99M | 43.84%5.31M | 1,265.39%5.53M | 27.53%1.64M | 416.60%6.6M | |
| Income before tax | 129.32%146K | -303.72%-9.8M | -517.46%-7.44M | -111.68%-3.15M | -76.97%1.5M | 49.70%-498K | 420.15%4.81M | 206.33%1.78M | 41.18%-1.49M | 149.66%6.53M |
| Income tax | 1,204.00%276K | -46.41%527.66K | -127.94%-266K | -28.02%167K | -57.19%247K | -8.70%-25K | 15.18%984.71K | 34.48%952K | 405.26%232K | 157.59%577K |
| Net income | 72.52%-130K | -369.98%-10.32M | -964.78%-7.17M | -92.86%-3.32M | -78.89%1.26M | 51.09%-473K | 262.24%3.82M | 134.79%829K | 29.91%-1.72M | 148.91%5.95M |
| Net income continuous operations | 72.52%-130K | -369.98%-10.32M | -964.78%-7.17M | -92.86%-3.32M | -78.89%1.26M | 51.09%-473K | 262.24%3.82M | 134.79%829K | 29.91%-1.72M | 148.91%5.95M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 72.52%-130K | -369.98%-10.32M | -964.78%-7.17M | -92.86%-3.32M | -78.89%1.26M | 51.09%-473K | 262.24%3.82M | 134.79%829K | 29.91%-1.72M | 148.91%5.95M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 72.52%-130K | -369.98%-10.32M | -964.78%-7.17M | -92.86%-3.32M | -78.89%1.26M | 51.09%-473K | 262.24%3.82M | 134.79%829K | 29.91%-1.72M | 148.91%5.95M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 50.00%-0.0001 | -325.25%-0.0046 | -900.00%-0.0032 | -50.00%-0.0015 | -84.62%0.0006 | 77.78%-0.0002 | 196.19%0.002 | 118.84%0.0004 | 54.55%-0.001 | 85.71%0.0039 |
| Diluted earnings per share | 50.00%-0.0001 | -325.25%-0.0046 | -900.00%-0.0032 | -50.00%-0.0015 | -84.62%0.0006 | 77.78%-0.0002 | 196.19%0.002 | 118.84%0.0004 | 54.55%-0.001 | 85.71%0.0039 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.